Myths, Fantasies, and Rumors about Water System Design - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

KeywordLocation
About Search
Myths, Fantasies, and Rumors about Water System Design


Pharmaceutical Technology


The design of pharmaceutical water systems has always been part science and part alchemy, and unfortunately, it is not likely to change in the near future. Daily rhetoric is rife with statements from informed and intelligent people alleging design requirements that do not actually exist.



The problem is that if you do not have documentation from a reliable source that supports or contradicts these statements, they are nearly impossible to refute. As a result, they are often incorporated into system design.

Take, for example, the use of bacteria-retentive filtration in a water system. For years, variants of the following alleged statement have circulated verbally: "FDA doesn't allow filters because it considers them to be band-aids on a badly designed system." As a result, many systems were designed without filters, rooted in a fear that the US Food and Drug Administration would disapprove. Meltzer et al., after researching this very subject, wrote that current FDA staffers indicated they would not disapprove a system simply because it contained these filters (1). Was this statement ever really made?

The answer is a qualified yes, as this author personally heard it numerous times from more than one FDA employee, albeit many years ago. None-theless, it was said in conversation and never written in an approved regulatory document or guide.

Written guidelines . . . or lack thereof

As far back as FDA's 1993 Guide to Inspections of High Purity Water Systems, one can find comments that, taken out of context, could be interpreted as support for either side of the argument.

For example, in that Guide, Section "X-Reverse Osmosis," paragraph 6 states, "The systems also contain 0.2 micron point of use filters which can mask the level of microbial contamination in the system" (2). It also goes on in the same paragraph to state, "If filters are used in a water system there should be a stated purpose for the filter, i.e., particulate removal or microbial reduction, and an SOP stating the frequency with which the filter is to be changed" (2).

Hence, in spite of the urban legend, it does not appear that FDA ever took a definitively negative stance against bacteria-retentive filtration, although some individual inspectors did so, possibly based on a specific system design or set of individualized circumstances.

What's missing.The normally accepted design criteria for US Pharmacopeia (USP) water systems (purified and water-for-injection) are neither published by FDA nor are they tabularized in a recognized volume for easy review and discussion, although much is written about them by industry pundits. Nonetheless, most or all of the writings include at least some of the items listed in the sidebar, "Commonly accepted design criteria for USP water systems." Some of the items listed in the sidebar are supported in reliable resources, but many are not, and few confirmations exist in regulatory print.

Regardless of whether these items are documented in the literature or not, they are very often accepted by owners, engineers, designers, users, validation experts, and operations personnel as rules or laws.

The good news is that none of these features, properly applied, have ever compromised a water system, although some absolutists have come very close. Consider the example of the engineer who insisted an 1100-ft long, 2-in. line be pitched ⅛ in./ft even though the roof elevation was only 12 ft (it took a contractor with a jackhammer to make the point).

Microbial control. What is paramount and possibly not obvious is that of the items listed in the sidebar, every one relates either directly or indirectly to microbial control or sanitization of the system.

The reason for so much focus on sanitization is that achieving the required chemical purity for USP waters (they're basically the same for purified and water-for-injection) is fairly simple with available technologies. Keeping the system under microbiologic control, however, takes finesse.


ADVERTISEMENT

RELATED CONTENT
From Quality by Inspection to Quality by Design: A Roadmap for Success
Out-of-Specification Results and the Quality System Approach to GMPs
Supporting GMPs During the Product Life Cycle in Contract Manufacturing
Myths, Fantasies, and Rumors about Water System Design
A Review of Statistical Outlier Methods
post a comment
Your email address will NOT be published.
appears with your comment
read our privacy policy
Note: does not support HTML
All comments submitted are subject to review, and may be delayed before posting. We reserve the right not to post comments.
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What factor do you think will be most significant in 2010 for determining the health of the market for contract manufacturing of active pharmaceutical ingredients?
The global economic recovery
The US economic recovery
Improved credit and financing flow to the small to emerging pharma/bio sector
Less restrictive inventory control by pharmaceutical companies
The level of competition from contract manufacturers in emerging markets
The global economic recovery
39%
The US economic recovery
14%
Improved credit and financing flow to the small to emerging pharma/bio sector
15%
Less restrictive inventory control by pharmaceutical companies
8%
The level of competition from contract manufacturers in emerging markets
24%
View Results
Eric LangerOutsourcing OutlookEric Langer A Bio View of Outsourcing
Patricia Van ArnumIngredients InsiderPatricia Van Arnum Advances in Custom Synthesis
Faiz kermaniSpotlightFaiz Kermani EU pricing dilemmas
Faiz kermaniStatistical Solutions Lynn Torbeck%RSD: Friend or Foe?
Keep an eye on that cargo
Pharma packs a punch
Another Boost for Vaccines
Rodney Dangerfield and R&D
Federal Spending Freeze Could Threaten Supply-Chain Security
FindPharma Custom Search
Source: Pharmaceutical Technology,
Click here